Tata India Pharma & Healthcare Fund vs ITI Pharma and Healthcare Fund Regular compare
ITI Pharma and Healthcare Fund Regular - Growth
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Fund | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High Risk | Very High |
Asset Size (Cr) | ₹217 Cr | ₹1208 Cr |
Min Investment | ₹5000 | ₹5000 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹1000 |
Launch Date | 08 Nov 2021 | 28 Dec 2015 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | NIFTY Healthcare TRI | Nifty Pharma TRI |
Turn Over | % | 26.49% |
Expense Ratio | 2.35 | 2.14 |
Manager | Rohan Korde | Meeta Shetty |
ISIN Code | INF00XX01BL5 | INF277K016A9 |
Exits Load | ITI Pharma & Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Month | -7.34% | -7.82% |
6 Month | -6.6% | -8.67% |
1 Year | 9.8% | 8.93% |
3 Year | 17.76% | 18.99% |
5 Year | - | 22.08% |
SIP Return Analysis
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
6 Month | - | - |
1 Year | 0.71% | 1.05% |
3 Year | 20.99% | 22.81% |
5 Year | - | 19.82% |
Rolling Lumpsum Returns
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
1 Year | 24.79% | 7.82% |
3 Year | 19.26% | 17.79% |
5 Year | - | 14.55% |
Risk Management
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Standard Deviation | 15.667% | 15.471% |
Sharp | 0.739% | 0.874% |
Beta | 0.959% | 0.953% |
Alpha | -1.413% | 0.602% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Name | Rohan Korde | Meeta Shetty |
Total AUM | ₹4626 Cr | ₹17847 Cr |
Fund Manage | 10 | 5 |
ITI Pharma and Healthcare Fund Regular - Growth | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.8 | 5.39 |
Large Cap | 38.11 | 40.33 |
Mid Cap | 26.43 | 30.82 |
Small Cap | 33.66 | 23.46 |
Sector Allocation
Scheme Name |
ITI Pharma and Healthcare Fund Regular - Growth |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
---|---|---|
Others | 1.8 | 5.39 |
Pharmaceuticals & Biotechnology | 77 | 76.28 |
Healthcare Services | 18.01 | 14.31 |
Chemicals & Petrochemicals | 0.96 | 0.39 |
Fertilizers & Agrochemicals | 1.03 | 0.83 |
Insurance | 1.2 | 2.14 |
Retailing | - | 0.66 |
Top Comparisons
Axis Strategic Bond Fund - Regular Plan - Growth Option
3Y Returns6.69%
HSBC Medium Duration Fund - Regular Growth
3Y Returns6.07%
HDFC Equity Savings Fund - GROWTH PLAN
3Y Returns9.23%
Axis Equity Savings Fund - Regular Plan - Growth
3Y Returns8.11%
HDFC Large and Mid Cap Fund - Growth Option
3Y Returns18.32%
LIC MF Large & Mid Cap Fund Regular-Growth
3Y Returns13.28%
Aditya Birla Sun Life Active Debt Multi Manager FoF Scheme - Regular Plan - Growth Option
3Y Returns6%
Kotak Income Plus Arbitrage FOF-Regular Plan-Growth
3Y Returns0%